Brief: Lineage Cell Therapeutics Reports Second Quarter 2020 Financial Results And Provides Update On All Clinical Programs
06/08/2020 22:23
Lineage Cell Therapeutics Inc LCTX.A :
* LINEAGE CELL THERAPEUTICS REPORTS SECOND QUARTER 2020
FINANCIAL
RESULTS AND PROVIDES UPDATE ON ALL CLINICAL PROGRAMS
* Q2 REVENUE $400,000 VERSUS $800,000
* Q2 REVENUE ESTIMATE $558,000 -- REFINITIV IBES DATA
Source text for Eikon: ID:nBw1vlW1Da
Further company coverage: LCTX.A
Recent news on Lineage Cell Therapeutics
See all newsLineage Cell Therapeutics Q2 revenue falls but posts profit
Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million
Lineage Cell Therapeutics Q1 net loss widens as expenses rise
Lineage Cell Q4 revenue rises on Genentech collaboration
Brief: Lineage Cell Therapeutics FY Income From Operations USD -36.619 Million